April 22nd 2024
An additional seven lots of Treprostinil are affected on top of last month’s recall of one lot.
April 2nd 2024
March 29th 2024
AAM: Market Factors Contribute to Drug Shortage Crisis
August 2nd 2023The Association for Accessible Medicines (AAM) published a white paper on the impact that ongoing drug shortages have had on the generic and biosimilar industries, as well as possible solutions stakeholders can put into action.
Read More
Quality Issues Lead to Shortages of Common Cancer Drugs
June 12th 2023More than 90% of cancer centers have experienced shortages of critical drugs. Erin R. Fox, Pharm.D., University of Utah Health, talks about why these shortages are happening and efforts that are being made to address them.
Read More
FDA Warns About Certain Compounded Semaglutide Products
June 7th 2023The FDA has received adverse event reports after patients have used compounded semaglutide that contains salt formulations, which are different active ingredients than that used in the agency-approved drugs for diabetes and weight loss.
Read More